Stay updated on Oral Azacitidine with Pembrolizumab in Metastatic Melanoma Clinical Trial
Sign up to get notified when there's something new on the Oral Azacitidine with Pembrolizumab in Metastatic Melanoma Clinical Trial page.

Latest updates to the Oral Azacitidine with Pembrolizumab in Metastatic Melanoma Clinical Trial page
- Check4 days agoChange DetectedThe page's revision stamp has been updated from v3.5.4 to v3.5.5, signaling a minor maintenance update to the page template rather than a change to study content.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4, indicating a new published version of the page. This update pertains to the page's revision metadata rather than substantive content changes.SummaryDifference0.1%

- Check40 days agoChange DetectedRevision metadata on the page was updated from v3.5.2 to v3.5.3, indicating a minor version update to the page.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed.SummaryDifference0.1%

- Check62 days agoChange DetectedThe study status was updated from Active, not recruiting to Completed, with revised completion/update dates.SummaryDifference0.5%

- Check76 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Oral Azacitidine with Pembrolizumab in Metastatic Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Azacitidine with Pembrolizumab in Metastatic Melanoma Clinical Trial page.